Early dynamic changes in iPSC oxygen consumption rate predict future cardiomyocyte differentiation.

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cardiovascular Research

Background:

• Human induced pluripotent stem cells (iPSCs) offer potential for cardiovascular disease treatment through cardiomyocyte replacement.
• Current iPSC-derived cardiomyocyte differentiation is lengthy, variable, and challenging for manufacturing.
• Real-time, label-free quality control is needed for efficient iPSC-derived cardiomyocyte production.

Purpose of the Study:

• To identify early, predictive quality attributes for induced pluripotent stem cell-derived cardiomyocyte differentiation.
• To assess the utility of oxygen consumption rate as a real-time control metric.

Main Methods:

• Monitoring live oxygen consumption rate during the initial 72 hours of iPSC differentiation.
• Correlating oxygen consumption rate with final cardiomyocyte differentiation outcome.

Main Results:

• Oxygen consumption rate measurements accurately predicted cardiomyocyte differentiation outcome (93% accuracy).
• This predictive capability was achieved as early as 72 hours into the differentiation protocol.
• The method is readily translatable to existing bioreactor technology.

Conclusions:

• Live oxygen consumption rate is a highly predictive quality attribute for iPSC-derived cardiomyocyte manufacturing.
• Early detection of differentiation deviations can save time and resources.
• This approach facilitates the clinical translation of iPSC-based cardiovascular therapies.